Skip to main content
Clinical Trials/NCT05601609
NCT05601609
Completed
Not Applicable

Are Sporadic Colorectal Cancers in Young Distinct From Elderly?

Seoul National University Bundang Hospital1 site in 1 country1,599 target enrollmentNovember 11, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colorectal Neoplasms
Sponsor
Seoul National University Bundang Hospital
Enrollment
1599
Locations
1
Primary Endpoint
Overall survival outcome in young colorectal cancer (yCRC) and elderly colorectal cancer (eCRC)
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

In this study, the investigators compared and evaluated the clinicopathological and oncological characteristics of sporadic colorectal cancer (CRC) in young adults without genetic mutations associated with hereditary CRC syndrome and sporadic CRC in elderly individuals.

Detailed Description

The ambiguity in the findings among several previous studies might be because of the difference in the age of the study population, yCRC and eCRC. The family history of CRC and cancer due to Crohn's disease or ulcerative colitis were also not excluded in such previous studies. Most importantly, those studies did not rule out the risk of hereditary cancer through the genetic testing in yCRC. Since hereditary CRC accounts for approximately 34% of those under the age of 35 years, it is necessary to exclude it to accurately compare the clinicopathological characteristics of sporadic cancer developed in yCRC and eCRC.

Registry
clinicaltrials.gov
Start Date
November 11, 2020
End Date
August 2, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Histologically confirmed cases of adenocarcinoma in the colon and rectum
  • The age at the time of diagnosis should be ≤ 40 years (for yCRC) or ≥ 70 years (for eCRC)
  • Genetic testing confirmation of non-hereditary cancer.

Exclusion Criteria

  • Inflammatory bowel disease
  • A family history of CRC
  • A history of other cancers
  • Underwent any emergency operation or palliative surgery
  • The Amsterdam criteria with mutations in genes associated with APC, MLH1, MSH2, MSH6

Outcomes

Primary Outcomes

Overall survival outcome in young colorectal cancer (yCRC) and elderly colorectal cancer (eCRC)

Time Frame: The OS was defined as the time period from the date of surgery to the date of death or last follow-up up to 3 years

The 3-year overall survival (OS) in yCRC and eCRC

Secondary Outcomes

  • Cancer-specific survival outcome in young colorectal cancer (yCRC) and elderly colorectal cancer (eCRC)(CSS was defined as the time period from the date of surgery to the date of death from CRC up to 3years)

Study Sites (1)

Loading locations...

Similar Trials